Search

everythinglearnresearchcommunity

for

Search:↓

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

New cancer treatments aim to reduce side effects and improve effectiveness.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Lipids are crucial for healthy hair, protecting it from damage and breakage.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Analog 23 is a promising compound for prostate cancer treatment.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Ayurvedic treatment may improve quality of life for cancer patients undergoing chemo and radiotherapy.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Mutations in certain receptors can cause diseases and offer new treatment options.